INZY – inozyme pharma, inc. (US:NASDAQ)
Stock Stats
News
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency [Yahoo! Finance]
Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference
Form 4 Inozyme Pharma, Inc. For: Apr 01 Filed by: Treco Douglas A
Form 4 Inozyme Pharma, Inc. For: Mar 31 Filed by: Winton Matthew
Form 4 Inozyme Pharma, Inc. For: Mar 31 Filed by: Subramanian Sanjay
Form 4 Inozyme Pharma, Inc. For: Mar 11 Filed by: Subramanian Sanjay
Form 4 Inozyme Pharma, Inc. For: Mar 11 Filed by: Winton Matthew
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.